Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("LEEN, Ann M")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 21 of 21

  • Page / 1
Export

Selection :

  • and

Cytotoxic T lymphocytes as immune-therapy in haematological practiceLEEN, Ann M; HESLOP, Helen E.British journal of haematology. 2008, Vol 143, Num 2, pp 169-179, issn 0007-1048, 11 p.Article

Adenovirus as an emerging pathogen in immunocompromised patientsLEEN, Ann M; ROONEY, Cliona M.British journal of haematology. 2005, Vol 128, Num 2, pp 135-144, issn 0007-1048, 10 p.Article

How I treat adenovirus in hematopoietic stem cell transplant recipientsLINDEMANS, Caroline A; LEEN, Ann M; JAN BOELENS, Jaap et al.Blood. 2010, Vol 116, Num 25, pp 5476-5485, issn 0006-4971, 10 p.Article

Generation of Polyclonal CMV-specific T Cells for the Adoptive Immunotherapy of GlioblastomaGHAZI, Alexia; ASHOORI, Aidin; HEGDE, Meenakshi et al.Journal of immunotherapy (1997). 2012, Vol 35, Num 2, pp 159-168, issn 1524-9557, 10 p.Article

Allogeneic virus-specific T cells with HLA alloreactivity do not produce GVHD in human subjectsMELENHORST, J. Joseph; LEEN, Ann M; BOLLARD, Catherine M et al.Blood. 2010, Vol 116, Num 22, pp 4700-4702, issn 0006-4971, 3 p.Article

Generation of Tumor Antigen-Specific T Cell Lines from Pediatric Patients with Acute Lymphoblastic Leukemia―Implications for ImmunotherapyWEBER, Gerrit; CARUANA, Ignazio; ROUCE, Rayne H et al.Clinical cancer research (Print). 2013, Vol 19, Num 18, pp 5079-5091, issn 1078-0432, 13 p.Article

Improving T-cell Therapy for Relapsed EBV-Negative Hodgkin Lymphoma by Targeting Upregulated MAGE-A4CRUZ, Conrad R; GERDEMANN, Ulrike; ROONEY, Cliona M et al.Clinical cancer research (Print). 2011, Vol 17, Num 22, pp 7058-7066, issn 1078-0432, 9 p.Article

Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantationLEEN, Ann M; CHRISTIN, Anne; BRENNER, Malcolm K et al.Blood. 2009, Vol 114, Num 19, pp 4283-4292, issn 0006-4971, 10 p.Article

Genetic Modification of T Cells With IL-21 Enhances Antigen Presentation and Generation of Central Memory Tumor-specific Cytotoxic T-lymphocytesKAKA, Anjum S; SHAFFER, Donald R; HARTMEIER, Ryan et al.Journal of immunotherapy (1997). 2009, Vol 32, Num 7, pp 726-736, issn 1524-9557, 11 p.Article

Oncolytic Immunotherapy of Advanced Solid Tumors with a CD40L-Expressing Replicating Adenovirus: Assessment of Safety and Immunologic Responses in PatientsPESONEN, Sari; DIACONU, Iulia; HAAVISTO, Elina et al.Cancer research (Chicago, Ill.). 2012, Vol 72, Num 7, pp 1621-1631, issn 0008-5472, 11 p.Article

Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transferBOLLARD, Catherine M; GOTTSCHALK, Stephen; GRESIK, M. Victoria et al.Blood. 2007, Vol 110, Num 8, pp 2838-2845, issn 0006-4971, 8 p.Article

Fiber-modified adenoviruses generate subgroup cross-reactive, adenovirus-specific cytotoxic T lymphocytes for therapeutic applicationsLEEN, Ann M; SILI, Uluhan; SAVOLDO, Barbara et al.Blood. 2004, Vol 103, Num 3, pp 1011-1019, issn 0006-4971, 9 p.Article

Immunotherapeutic strategies to prevent and treat human herpesvirus 6 reactivation after allogeneic stem cell transplantationGERDEMANN, Ulrike; KEUKENS, Laura; BRENNER, Malcolm K et al.Blood. 2013, Vol 121, Num 1, pp 207-218, issn 0006-4971, 12 p.Article

Accelerated Production of Antigen-specific T Cells for Preclinical and Clinical Applications Using Gas-permeable Rapid Expansion Cultureware (G-Rex)VERA, Juan F; BRENNER, Lara J; ROONEY, Cliona M et al.Journal of immunotherapy (1997). 2010, Vol 33, Num 3, pp 305-315, issn 1524-9557, 11 p.Article

Functionally active virus-specific T cells that target CMV, adenovirus, and EBV can be expanded from naive T-cell populations in cord blood and will target a range of viral epitopesHANLEY, Patrick J; YOUNG CRUZ, Conrad Russell; ROONEY, Cliona M et al.Blood. 2009, Vol 114, Num 9, pp 1958-1967, issn 0006-4971, 10 p.Article

Using Dendritic Cell Maturation and IL-12 Producing Capacity as Markers of Function : A Cautionary TaleKAKA, Anjum S; FOSTER, Aaron E; WEISS, Heidi L et al.Journal of immunotherapy (1997). 2008, Vol 31, Num 4, pp 359-369, issn 1524-9557, 11 p.Article

Derivation of human T lymphocytes from cord blood and peripheral blood with antiviral and antileukemic specificity from a single culture as protection against infection and relapse after stem cell transplantationMICKLETHWAITE, Kenneth P; SAVOLDO, Barbara; HESLOP, Helen E et al.Blood. 2010, Vol 115, Num 13, pp 2695-2703, issn 0006-4971, 9 p.Article

Exploiting Cytokine Secretion to Rapidly Produce Multivirus-specific T Cells for Adoptive ImmunotherapyFUJITA, Yuriko; LEEN, Ann M; JIALI SUN et al.Journal of immunotherapy (1997). 2008, Vol 31, Num 7, pp 665-674, issn 1524-9557, 10 p.Article

Identification of Hexon-Specific CD4 and CD8 T-Cell Epitopes for Vaccine and ImmunotherapyLEEN, Ann M; CHRISTIN, Anne; KHALIL, Mariam et al.Journal of virology. 2008, Vol 82, Num 1, pp 546-554, issn 0022-538X, 9 p.Article

Autologous designer antigen-presenting cells by gene modiication of T lymphocyte blasts with IL-7 and IL-12FOSTER, Aaron E; LEEN, Ann M; LEE, Timothy et al.Journal of immunotherapy (1997). 2007, Vol 30, Num 5, pp 506-516, issn 1524-9557, 11 p.Article

Conserved CTL epitopes on the adenovirus hexon protein expand subgroup cross-reactive and subgroup-specific CD8+ T cellsLEEN, Ann M; SILI, Uluhan; VANIN, Elio F et al.Blood. 2004, Vol 104, Num 8, pp 2432-2440, issn 0006-4971, 9 p.Article

  • Page / 1